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Resumo  
 
O Toxoplasma gondii é um parasita humano bem-sucedido que infecta milhões de 
pessoas em diversos países. Em indivíduos imunodeprimidos, o parasita causa uma 
doença severa com diversas manifestações clinicas. No entanto, os indivíduos 
imunocompetentes são assintomáticos, podendo este parasita persistir no hospedeiro 
por um longo período de tempo. Nas mulheres grávidas, uma primo-infeção com T. 
gondii pode levar a severas manifestações clinicas, como por exemplo, ao aborto ou a 
malformações do feto, como coriorretinite, hidrocefalia e encefalites. Assim, é 
importante entender os mecanismos e as células imunológicas envolvidas na resposta 
à infeção com este parasita tanto a nível sistémico como a nível da interface feto-
materna. Neste trabalho, tivemos como principais objetivos: determinar o efeito da 
infeção nos parâmetros básicos da função reprodutiva durante a gravidez; 
quantificação do T. gondii em vários tecidos e células; e a análise de neutrófilos, 
macrófagos e populações de células T nas células esplénicas e do exsudado 
peritoneal. Para a infeção, usou-se uma estirpe do tipo II de T. gondii e murganhos 
Balb/c gestantes e não gestantes. Análises macroscópicas foram realizadas para 
avaliar os locais de implantação. Para a quantificação do parasita foi realizada a 
técnica de Real-Time PCR quantitativo. As populações de neutrófilos, macrófagos e 
células T foram avaliadas por citometria de fluxo. Os resultados obtidos neste trabalho 
demonstraram, que após 5 dias de infeção com T. gondii Me49 não ocorreu a 
disseminação do parasita desde do local da infeção (cavidade peritoneal) até ao 
pulmão, coração e rim. Foi no entanto, possível confirmar a disseminação sistémica do 
parasita após 7 dias de infeção. Neste trabalho foi possível efetuar a deteção e 
quantificação de células do exsudado peritoneal - T. gondii+ pela técnica de citometria 
de fluxo para 5 e 7 dias após infeção. A análise da expressão de moléculas MHCII por 
citometria de fluxo, indicou um aumento significativo da expressão de MHCII nos small 
peritoneal macrophages comparativamente aos large peritoneal macrophages, nos 
murganhos não gestantes ou gestantes, não infetados. Foi demonstrado que após 7 
dias de infeção a população dos large peritoneal macrophages é inexistente em 
murganhos não gestantes ou gestantes. Ao nível do baço, foi possível verificar uma 
diminuição significativa da percentagem da população CD11b+F4/80+MHCII+ e uma 
diminuição na expressão de MHCII nestas células, no dia 12 de gravidez durante a 
infeção com T. gondii. Estes resultados sugerem que T. gondii poderá influenciar vias 
dependentes da gravidez, interferindo com a capacidade da apresentação antigénica. 
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Abstract 
 
Toxoplasma gondii is a successful human parasite, which infects millions of people in 
several countries in the world. In immunosuppressed individuals, the parasite causes a 
severe disease with many clinical manifestations. However, immunocompetent 
individuals are asymptomatic, but this parasite persists for long periods of time. In 
pregnant women, T. gondii primo-infection can lead to a variety of severe clinical 
manifestations, like abortion or fetal malformations, as chorioretinitis, hydrocephalus 
and encephalitis. Therefore, is important to understand the immunological mechanisms 
and cell players involved in T. gondii immune response at the systemic level and 
maternal-fetal interface. In this work, the principal aims were: to determine the effect of 
infection in basic parameters of reproductive function in pregnancy; T. gondii 
quantification in tissues and cells; and neutrophil, macrophage and T cell populations 
analysis in spleen and peritoneal exudate cells. Infection using a type II strain of 
T.gondii of pregnant and non-pregnant Balb/c mice, allowed the follow-up of 
pregnancy. Macroscopic analyses were performed to evaluate implantation sites. The 
quantification of the parasite was performed by quantitative Real-Time PCR. 
Neutrophil, macrophage and T cell populations were evaluated by flow cytometry 
analysis. The results obtained, indicated that 5 days of infection were not sufficient for 
the parasite dissemination from the local of infection (intraperitoneal cavity) to the lung, 
heart and kidney. However, it was possible to confirm systemic parasite dissemination 
after 7 days of infection. The data obtained indicated that flow cytometry technique is 
sensible to detect peritoneal exudate cells-T. gondii+ at 5 and 7 days post-infection. 
MHCII expression was significantly increased in small peritoneal macrophages 
compared to large peritoneal macrophages from uninfected non-pregnant or pregnant 
mice. It was demonstrated that large peritoneal macrophages are inexistent after 7 
days of T. gondii infection in non-pregnant or pregnant mice. At spleen level, it was 
found a significant decrease in the percentage of CD11b+F4/80+MHCII+ and a MHCII+ 
expression down-regulation in CD11b+F4/80+, at day 12 of pregnancy during T.gondii 
infection. These results, suggest that T. gondii may be influencing pregnancy-
dependent pathways, interfering with the capacity of antigen presentation. 
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Introduction 
 
1. Toxoplasma gondii 
 
T.gondii is an important group of obligate intracellular protozoan of the Phylum 
Apicomplexa, subclass coccidian, order Eimeriorina and family toxoplasmatidae (1,2). 
The cat constitutes the definitive host and other warm-blooded animals, such as 
humans, are the intermediate hosts (3). The first report of T.gondii occurred in 1908 by 
Charles Nicolle and Manceuax using tissues of hamster-like rodent, Ctenodactylus 
gundi, which was used in leishmaniasis research in the North Africa. Initially, they 
believed that the parasite found was Leishmania. However, they realized that it was a 
new organism and named it as T. gondii (4). This name derived from its crescent-
shaped morphology of tachyzoite the Toxo means “arc form” in Greek and gondii 
derived from the first found host (5). At the same time another scientist, Alfonso 
Splendore, discovered a similar parasite in rabbits in Brazil (6).  
In the next years, T. gondii was found in several other hosts, mainly in avian 
species (7). However, only in 1937 Sabin and Olitsky isolated, for the first time, viable 
T. gondii from the animal host and in 1941, they proved that human T. gondii was 
identical to the parasite present in other hosts (8). Later in 1940’s antibodies were 
detected and found to kill extracellular but not intracellular tachyzoites (8,9). In 1970 
the life cycle of this parasite was discovered, allowing a better understanding of 
T.gondii transmission (10).  In the course of 1980’s and 1990’s various methods, were 
developed to recognize genetic differences between T. gondii isolates from animals 
and humans (11–14). Many advances have been achieved due to T. gondii genes 
mapping helping in the search of better antigens for the diagnosis, prevention and the 
knowledge of disease mechanisms (15).  
T.gondii infects millions of people in the world and is the most successful human 
parasite (16). This parasite can cause severe clinical manifestations specifically in two 
distinct cases:  immunodeficient individuals and primo-infected pregnant women. The 
primo-infection in pregnant women can lead to a congenital toxoplasmosis, with diverse 
clinical manifestations such as hydrocephalus, macrocephaly, encephalitis, seizures, 
calcifications, chorioretinitis, blindness in the fetus and may also result in intrauterine 
death and spontaneous abortion (17).  
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2. Parasite morphology and Life-cycle  
 
T. gondii present three infectious stages, such as sporozoites which disseminate in 
the environment within oocysts, tachyzoites which facilitate expansion during acute 
infection and bradyzoites which maintain the chronic infection being all the three stages 
haploid forms (Fig.1 ; 17,18).  
 
 
Fig. 1- Life cycle stages of T. gondii. A- Tachyzoites; B-Small tissue cysts; C- Tissue cysts; D- Unsporulated oocysts 
(2). 
The life cycle of this parasite has both asexual (schizogony) and sexual 
(gametogony) reproduction, which occur in the small intestine of the definitive host 
(Fig.2; 19). Tachyzoites and bradyzoites divide asexually, while sporozoites are the 
parasite forms obtained after sexual reproduction (21). 
The sexual phase or gametogony occurs throughout the small intestine and in the 
ileum. The microgamete (the male gamete) is biflagellate and fertilizes the 
macrogamete (the female gamete) within the enterocyte. The fertilization initiates 
oocysts wall formation, and the product of this sexual reproduction is the zygote. The 
oocysts are released into the intestinal lumen by rupture of the epithelial cells and 
thereafter excreted in cat feces (18). The oocysts release, from the epithelial cells, 
takes 3 to 10 days after ingesting of bradyzoites, >18 days after ingesting of sporulated 
oocysts and >13 days after ingesting of tachyzoites (22). Sporogony occurs outside of 
the host within 1-5 days after excretion, depending on atmospheric conditions, such as 
aeration, humidity, and temperature. Each oocyst contains two sporocysts, which 
contain four sporozoites (18). 
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Fig. 2- The different infectious stages of T.gondii life cycle, i.e. tachyzoites, bradyzoites contained in tissues cysts 
and sporozoites contained in sporulated oocysts (23). 
 
The asexual phase can occur after ingesting the tissue cysts or infectious oocysts 
(23). After this ingestion by an intermediate host (such as humans), the sporozoites are 
released from the oocysts, penetrate the intestine, invade a range of different cell types 
and multiply asexually, as tachyzoites (24). This parasite form is crescent or oval and is 
present during acute infection and multiply rapidly in a wide variety of nucleated cell 
hosts, within the parasitophorous vacuole (21,25). The parasite invasion is due to an 
actin-based motility, being the formation of this vacuole derived from the host cell 
plasma membrane and secretion of parasite proteins (26). The tachyzoites divide every 
6-9h by a process denominated endodyogeny, in which daughter cells form multiply 
within the mother cell (27). After replication, the host cells are disrupted, and the 
tachyzoites disseminated through the bloodstream, infecting many tissues, including 
the CNS, eye, skeletal, and heart muscles, placenta leading that way to diverse clinical 
manifestations (25).  Finally in response to environmental conditions, the tachyzoites 
converts into bradyzoites forming the tissue cysts, present in different organs and 
tissues (Fig. 3; 27). Bradyzoites replicated slowly by endodyogeny, they are 
morphologically identical to tachyzoites and are considered as the latent form able to 
remain in the tissues for the entire host life (18,21,25). 
Depending on several environment factors, the tissue cysts can rupture and 
bradyzoites forms can convert to tachyzoites resulting in the reactivation of infection. 
This reactivation may result in various clinical manifestations, as toxoplasmic 
encephalitis, an opportunistic disease which can occur in immunodeficient patients 
(18). 
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  Fig. 3- The life cycle of T. gondii  (2). 
 
3. Transmission  
 
The transmission of Toxoplasma gondii may occur in three different ways: Tissue 
cyst transmission, congenital transmission, and oocyst transmission. However, it can 
also occur by organ transplantation or laboratory infection (Fig. 4). In the next subtitles 
it each of the routes of transmission will be exposed.  
3.1. Tissue cyst transmission 
  
In 1954 Weinman and Chandler suggested that transmission could occur through 
the ingestion of undercooked meat. Later on, in 1960, Jacobs et al. provided evidence 
to support this idea, demonstrating that T. gondii was resistant to proteolytic enzymes 
due to T. gondii forms derived from cysts (29). Nowadays, we know that the primo-
infection of cats can occur by eating infected prey, such as rodents, birds, initiating the 
sexual reproduction and production of oocysts in small intestine (30). Although, 
intermediate hosts can also acquire toxoplasmosis via ingestion of tissue cysts (20) 
Intermediate hosts, such as pigs, sheep, and goats, can present tissue cysts in 
muscle and brain. Therefore, Human can acquire the infection with T. gondii through 
the ingestion or handling of undercooked or raw meat from infected animals (25). After 
ingestion, the cyst wall can usually suffer a rupture by proteolytic enzymes in the 
stomach, occurring the release of bradyzoites, which are resistant to proteolytic 
digestion, and therefore they survive and initiate the infection in the small intestine (20).  
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3.2. Congenital transmission 
 
In 1939, three pathologists, Wolf, Cowen and Paige, identified the first case of 
Human congenital toxoplasmosis. They have then reported that the T.gondii infection 
was associated with encephalomyelitis, hydrocephalus, chorioretinitis and encephalitis 
in the developing fetus (31). Later on, these clinical manifestations were found in other 
animals species, such as sheep, goats, and rodents (32).  
3.3. Oocysts transmission  
 
For many years, the infection with T. gondii has been closely connected to 
carnivorism or congenital transmission. However, doesn’t explaining the widespread 
infection in vegetarians and herbivores. Therefore, in 1965, Hutchison discovered, the 
oocysts, the parasite form present in the cat feces (33). This new form was able to 
transmit the infection to mice and other intermediate hosts, being stable and able to 
survive for up to 12-18 months in the environment, depending on the climatic 
conditions (34).  
The cat is able to excrete up 10 million of oocysts per day, which sporulates in 1 to 
5 days, becoming infective (19). The oocyst form can contaminate soil, water, and 
food, like vegetables and fruits. Therefore, transmission can occur by the ingestion of 
contamined water, vegetable and fruits (35).   
3.4. Organ transplantation and laboratory infection   
 
Another route of transmission, which is less frequent is by the organ 
transplantation. Heart, heart-lung, kidney, liver, or liver-pancreas transplantation, can 
lead to the transmission of T. gondii by a seropositive donor to a seronegative receptor 
(25). In the laboratory, the technician can be infected by contacting with contaminated 
needles, glassware or infected tissues or blood derived products (25).  
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Fig. 4- Different pathways of T. gondii infection and transmission (36). 
 
4. Animal hosts   
 
T. gondii can cause infection, a severe disease and even mortality in diverse 
species of domestic and wild animals (37). In livestock animals, such as pigs, sheep 
and goats were, frequently, observed tissue cysts of T.gondii (23). In sheep and goats, 
the parasite may cause embryonic death and resorption, fetal death, abortion, stillbirth 
and neonatal death (38). However, in the case of cattle and horses, both presented 
resistance to the parasite (39). T. gondii infection is also very frequently in sea 
mammals, such as seals, dolphins, sea lions and others (37). Clinical toxoplasmosis 
has also been reported in several animals: carnivores (chinchillas, mink, ferrets, foxes, 
raccoons, skunk and black bears), wild pigs, wild felids, small mammals (rats, mice, 
rabbits, guinea pigs, squirrels), monkeys, marsupials and birds (38).   
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5. Humans infection  
 
In immunocompetent individuals the primo-infection with T.gondii is asymptomatic, 
but about 10 % of infected individuals became symptomatic, with the development of 
lymphadenopathy (40), accompanied by fever, malaise, night sweats, myalgias, sore 
throat, maculopapular rash, abdominal pain, hepatosplenomegaly and small numbers 
of atypical lymphocytes (41).  
In immunosuppressed patients, the clinical manifestation is more severe with 
splenomegaly, polymyositis, dermatomyositis, chorioretinitis, myocarditis, pneumonitis, 
hepatitis, encephalitis and multi-system organ failure (42). Ocular toxoplasmosis is the 
most common cause of chorioretinitis (43) and can be acquired congenitally, but it can 
also be developed at the post-natal period or can be a result of infection reactivation in 
immune-compromised and/or pregnant individuals (44). The toxoplasmic chorioretinitis 
cause decreased vision, blindness or glaucoma. (43). In the case of acute 
chorioretinitis symptoms like blurred vision, scotoma, pain, photophobia, epiphora or 
loss of central vision may occur (41). Encephalitis is the most frequent manifestation of 
T.gondii disease characterized by a unifocal or multifocal lesion at the central nervous 
system in immunosuppressed individuals (45,46). The symptomatology consists of 
headache, fever, psychomotor or behavioral changes, confusion, lethargy, 
hemiparesis, seizures, ataxia and cranial nerve palsies (46). AIDS positive individuals 
represent the majority of immunosuppressed patients exhibiting this clinical form (47).   
5.1. Congenital toxoplasmosis  
 
Congenital toxoplasmosis can occur when a woman acquires T.gondii infection for 
the first time during pregnancy. The infection occurs through the transplacental 
passage of the tachyzoites stage, thereby infecting the fetus (vertical transmission) 
(48). In the case of immunocompetent women that had been infected previously to  
their pregnancy, they are rarely reinfected (48). Although, it is described that 
reactivation of T. gondii latent infection occurs in immunocompromised women during 
pregnancy (49).    
The severity and incidence of congenital infection depends the amount of weeks of 
pregnancy in which the woman acquires the infection. In the first weeks the risk of 
transmission is low (5-25%) but the offspring presents severe clinical signs, which can 
result in spontaneous abortion, hydrocephaly, and mental retardation. Otherwise, in 
later weeks of pregnancy the risk of transmission increase (to 90%), but with less 
FCUP 
Determination of macrophages activation and T cell populations in context of congenital 
toxoplasmosis 
8 
 
clinical signs, such as chorioretinitis and potential blindness (Table 1; 19,49). Although 
some other clinical manifestations can occur, including miscarriage, fetal 
developmental retardation, encephalitis, microcephaly, intracranial calcifications, 
strabismus and epilepsy (51). 
The global maternal-fetal transmission rate in immunocompetent women who 
acquires primary T. gondii infection in pregnancy is approximately 29% (52) and in 
Europe, congenital toxoplasmosis affects normally 1 to 10 in 10 000 newborn babies 
(53). These numbers indicate that T. gondii infection is a worldwide problem and more 
research work is needed to understand parasite transmission and how the mother 
immune response can be determinant in controlling congenital toxoplasmosis.  
Table 1 – Risk of T. gondii congenital infection in different gestational age and development of clinical signs in the 
infected offspring. Adapted from (49).  
 
6. Epidemiology  
 
T. gondii infects approximately 25 to 30% of the human population in different 
areas of the world (Figure 6; 24). The seroprevalence depends on various factors, such 
as the environmental temperature. So in temperate countries, the range varies from 10 
to 50% and in tropics countries the range reaches over 80% (54). The lower 
seroprevalence ranges 10 to 30% have been reported in South East Asia, in Sahelian 
countries of Africa, as well as in cold climate areas such as Northern Europe and North 
America. However, moderate seroprevalences between 30 to 50% have been 
observed in countries of Southern and Central Europe, but high incidences have been 
observed in Latin America and tropical African countries (55).  
In the United States, a study of National Health and Examination Nutrition Survey 
(NHANES) demonstrate that T. gondii incidence decreased in U.S.-born persons aged 
between 12 to 49 years, from 14.1 % between 1988 to 1994 and to 9% in 1999 to 2004 
(56). Additionally, recent studies have shown that prior infection to pregnancy is 
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common, however when congenital toxoplasmosis occurs as prior infection is relatively 
uncommon and estimated from 400 to 4000  cases per year of this disease (57). 
In Europe, it is observed a declining in the T. gondii seroprevalence in pregnant 
women. In France, the seroprevalence in pregnant women were about 80% in the early 
1960’s, around 66% in the 1980’s, 54% in 1995 and 44% in 2003. At the same time, 
the average age rate of pregnant women enhanced (58). In the Netherlands, the 
seroprevalence declined from 35,2% in 1995-1996 to 18,5% in 2006- 2007 in women of 
reproductive age (59). 
 
Fig. 5- Global status of T. gondii seroprevalence .Dark red corresponding to prevalence about 60%, light red to 40-
60%, yellow 20-40%, blue 10-20 % and green < 10% of prevalence. The white zones equal absence data (60). 
Toxoplasmosis can also occurs among worldwide laboratory workers. A study 
based on a total of 47 laboratory-acquired cases have reported 81% of them as 
symptomatic cases (61). Many factors can affect seroprevalence in humans in different 
countries as climatic factors, influencing the survival of oocysts in the environment. 
Several anthropogenic factors including economic, social or cultural habits, dietary 
habits (hand washing, method of cooking meat, vegetable cleaning and kinds of meat 
or vegetables consumed, etc.), quality of water and sanitation coverage (55). However, 
in the case of infection in Europe, for instance, the high prevalence was justified by the 
choice of people for eating raw or undercooked meat.  Nevertheless, high prevalence 
in Central America and other developing countries has been attributed to the low socio-
economics status and frequency of stray cats in a climate favouring survival of oocysts 
(62).  
Another reason for the difference in prevalence in the several countries is the 
existence of three different genotypes, designated type I, II and III. Type I strain is 
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related to high-level virulence in mice and humans, and has been reported in patients 
with ocular toxoplasmosis, congenital disease, and AIDS patients. Type II is considered 
nonvirulent for mice but most commonly associated with human’s infections in Europe 
and North America reported in patients with congenital diseases and AIDS patients. 
Type III is nonvirulent for mice, but it is the most common strain in animals and 
detected in lower degree in humans (63).   
In conclusion, the parasite infects billions of people worldwide and the disease 
constitutes a public health problem. Therefore, it is necessary more and regular 
diagnosis in susceptible patients (pregnant and immunosuppressed people) and the 
search of more efficient treatment without secondary effects.  
7. Diagnosis  
 
The diagnosis of T.gondii can accomplish the three main assays:  
 Serological assays: is the primary method of diagnosis consisting on the 
detection of specific antibodies to T. gondii. For the IgG antibodies detection the 
test used is the Dye test (DT), the enzyme-linked immunosorbent assay 
(ELISA), the Modified agglutination test (MAT), the indirect fluorescent antibody 
test (IFAT). The test used to measure the IgM antibody are double-sandwich or 
capture IgM-ELISA kits, the IFAT and the IgM-ISAGA. This test is still used by 
most laboratories to determine if a patient has been infected recently or in the 
distant past. Thus, IgM antibodies can appear earlier in patients with primo-
infection, but decline more rapidly than IgG antibodies do. IgA antibodies can 
be detected in sera of infected adults or congenitally infected infants by the 
ELISA method. IgA antibodies can persist for many months or more than a year 
in the patient. Lastly, the IgE antibodies may be detectable by ELISA in 
congenitally infected infants, children with congenital toxoplasmic chorioretinitis 
and acutely infected adults. The period of IgE seropositivity is shorter compared 
to IgM or IgA antibodies being useful for identifying recently acquired infections 
(64). Although the diversity of serological tests, it's difficult to estimate when 
infection occurred in the case of maternal infection being dificult to manage the 
risk to the fetus properly. Recent assays have been proposed as the 
association of a sensitive test detecting T. gondii-specific IgM antibodies and 
allowing the measurement of the avidity of T.gondii IgG antibodies constituing a 
predictive assay to determine the time of infection. This assay has been 
denominated VIDAS avidity assay (65). Other recent methods, such as flow 
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cytometry analyses allow the detection of T. gondii antibodies, and proved to be 
quantitative and highly sensitive as compared with commonly used assays (66).  
 
 Molecular assays: The polymerase chain reaction (PCR) can detect infection 
by amplification of the T. gondii DNA in various body fluids (as amniotic fluids or 
cerebrospinal fluid) and tissue samples. This technique is useful in diagnosing  
congenital, cerebral, ocular and disseminated toxoplasmosis (67–69). Other 
recent and promising method is the loop-mediated isothermal amplification 
(LAMP). This approach is highly specific, sensitive and very useful in the 
diagnosis of parasite infections. Using a diverse type of samples like blood 
samples, water and urine (70,71). The LAMP assay may represent a useful and 
practical tool for the current diagnosis and therapeutic evaluation of human 
toxoplasmosis (71). 
 
 Image assay: it is frequently recommended ultrasound for women with 
suspected or confirmed acute infection acquired during or shortly before 
gestation. This imaging assay shows the presence of fetal abnormalities 
including splenomegaly, hydrocephalus, brain or hepatic calcification, and other 
lesions (49). To detect cerebral toxoplasmosis is actually used the magnetic 
resonance imaging (MRI), computed tomography (CT) or the positron emission 
tomography (PET) scans. These assays allow the monitorization of cerebral 
toxoplasmosis treatment (72,73).  
 
8. Treatment 
 
The current therapy of toxoplasmosis is based on drugs proved to be active against 
tachyzoites (the parasite form presents in the acute stage of toxoplasmosis), but not 
active to eliminate the tissue cysts stage (parasite form of chronic toxoplasmosis). 
Nowadays, the treatment recommended for acute toxoplasmosis is a combination of 
drugs: pyrimethamine and sulfadiazine plus folic acid  (73; Table 2). The treatment of 
congenital toxoplasmosis may be applied at the prenatal period to prevent the risk of 
mother-to-child transmission and at the postnatal period. Thus, if the maternal infection 
is detected before 18 weeks of gestation, the treatment recommended is spiramycin, to 
prevent vertical transmission of the parasite. After 18 weeks of pregnancy, the 
treatment recommended is pyrimethamine, sulfadiazine plus folic acid, avoiding a 
reduction of platelet count (74; Table 2).  
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Table 2 – Toxoplasmosis manifestations and their treatment indications. Adapted from (76). 
 
Other studies using different drugs as sulphonamides, pyrimethamine, 
trimethoprim, and clindamycin, alone or in combination, as well as ponazuril proved to 
be active for domestic cat treatment (77). 
Despite, the number of existent therapies, these are limited and not specific for 
toxoplasmosis. It is necessary the discovery of the new drugs able to eradicate the 
parasite form responsible for chronic toxoplasmosis and safer for the human organism. 
Recent studies have tested new drugs with a selective action on isoprenoid pathway, 
inhibitors of T.gondii enzymes as dihydrofolate reductase/thymidylate synthase and T. 
gondii adenosine kinase and T. gondii histone deacetylase (74,78). These new drugs 
may be a new promise and future treatment for T. gondii infection.     
 
9. Prevention and control  
 
Prevention of human toxoplasmosis can be done in two different ways: 
 Primary prevention: Seronegative women should be informed about how to 
prevent toxoplasmosis during pregnancy (79). The implementation of simple 
strategies in daily life to avoid infection such as: soap washing of kitchen 
surfaces, the utensils and the hands after having contacted with unwashed 
fruits or vegetables or/and raw meat; wearing gloves when gardening or 
changing cat litter; fruits and vegetables should be peeled or washed before 
eating (57). Meat  should be cooked at a high temperature (67ºC) to kill the 
parasite (80). The parasite can also be killed by exposure to extreme cold 
temperature (-13ºC) (81).  
 Secondary prevention: The prenatal and postnatal screenings allow the 
detection and treatments of recent T. gondii infection in pregnant women 
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able to reduce congenital toxoplasmosis prevalence (82). In European 
countries such as France, Austria, Switzerland, Germany, Italy and Belgium, 
applied programs have also shown the decrease of the prevalence of this 
disease (82,83). Serological test is regularly realized during pregnancy to 
detect T. gondii infection (82).  
In conclusion, the application of educational tools are necessary and extremely 
useful on the sensibilization to this disease, minimizing the risk of infection. 
Additionally, it is necessary the implementation of more effective screening programs in 
childbearing age or pregnant women.   
 
10. Maternal-fetal interface (FMI) and immune cell 
populations   
 
The maternal immune system, during a healthy pregnancy, changes in order to 
tolerate semi-allogeneic fetus without compromising the ability to protect the mother 
and the fetus against infection.   
Pregnancy implies an intimate association between the mother and developing 
fetus. In a typical situation, maternal tissues are not contacting directly with the 
developing fetus. This intimate connection is formed by the maternal-fetal interface 
(FMI), which included the maternal and fetal components, such as the decidua and the 
placenta, respectively (84). 
The maternal tissue, the decidua, is formed by a process called decidualisation. 
This process is vital for human pregnancy and responsible for providing a maternal 
immune tolerance, protection of the fetus and the modulation of the placentation (85). 
Placenta is a multifaceted organ that plays an essential role in maintaining and 
protecting the developing fetus. Placenta allows the nutrients apport from the mother to 
the fetus, substance secretion from the fetus, constituting a barrier to the fetus against 
pathogens and the maternal immune system, being an active endocrine organ too. It 
also has the capacity of synthesizing and secreting growth factors, hormones, cytokine 
and other bioactive products (86).  
In the placenta, there are specialized cells denominated trophoblasts, which play a 
major role in the implantation and development of the maternal-fetal interface (87). 
These fetal trophoblast cells are in close contact with maternal immune cells and the 
reason for this process is intimately associated with the Extravillous Trophoblast cells 
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(EVT), which invade the maternal uterine mucosa, namely the decidua during the 
pregnancy. Trophoblast invasion assures placenta anchoring within the uterine wall 
and the access of the fetus to the maternal vascular system ensuring the supply of 
oxygen and nutrients. In the first trimester of pregnancy the invasive capacity of EVT is 
stronger, but declines afterwards (88). Trophoblasts cells also play an essential role in 
materno-fetal infection and have importance concerning parasite transmission, 
because of their location between maternal and fetal blood circulation (89).  
During normal pregnancy, the maternal immune system can tolerate the paternal 
antigens present in placental tissue without immune rejection (84). To ensure materno-
fetal tolerance a specific immune cell population plays a crucial role denominated 
regulatory T cells (Treg) (90). However, this tolerance to fetal antigens can occur in the 
presence of a variety of other cell population.  
The immune populations present at the maternal-fetal interface are of maternal 
origin. Decidua is an active immunological tissue constituted by a broad population of 
maternal immune cells dynamically modifying in composition from ovulation throughout 
the course of pregnancy (91). More specifically the major population of decidual 
leukocytes present in the first trimester of pregnancy are: NK cells (~70%), 
Macrophages (~20%), T cell (~10-20%) including the regulatory T cells (Treg) and a 
small population of dendritic cells (DCs) (Figure 7; 88).  
 
Fig. 6 – Schematic representation of the maternal-fetal interface (FMI). MΦ: macrophages; NK: Natural killer cells; 
T: T cells; Treg: regulatory T cells; DC: dendritic cells; EVT: extravillous trophoblast cells (93). 
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10.1.  NK and Decidual NK cells 
 
NK cells play an important role in host defense, killing tumor and/or fetus virally 
infected cells (94) by secreting a variety of cytokines (95). In the T. gondii, context NK 
cell contributes to the initial host resistance parasite through the production of the 
effector cytokine IFN-ϒ (96). The development of NK cells occurs in the bone marrow, 
migrating after to the spleen, peripheral blood, and liver. Nevertheless, this cells can 
migrate into tissues in response to infectious and inflammatory stimulus  (97). 
NK cells constitute the dominant maternal immune cell population in the first 
trimester of decidua. After the first trimester, decidual NK cell (dNK) numbers decrease 
becoming  nearly absent at the term of pregnancy (95,98). The origin of dNK is not 
established, but several explanations have been proposed, such as: the maturation of 
endometrial NK cells in response to pregnancy-associated factors; the differentiation 
from hematopoietic precursors present in the decidua in response to decidual stromal 
factors; and the recruitment of peripheral blood NK cells that differentiate locally into 
dNK cells (99). dNK cells are in close contact with invasive placental trophoblasts, 
allowing the frequent interaction with other receptors (95). Specifically, dNK produce 
chemokines that attracting invasive trophoblasts, while trophoblasts express the 
receptors for that dNK produce chemokines (94). Thus, these cells have two important 
functions: helping the migration of trophoblast and promoting blood flow at the 
maternal-fetal interface (98).  dNK cells are responsible for the secretion of high levels 
of the angiogenic factors: endothelial growth factor (VEGF), angiopoietin-2 and 
placental growth factor (PIGF), as promoting angiogenesis the maternal-fetal interface 
and vasculogenesis on the fetal side (95,99). Additionally,  dNK cells have the capacity 
to produce cytokines and growth factors such as tumor necrosis factor-α (TNF-α), 
interleukin (IL)-10 and (IL)-1 β, transforming growth factor (TGF-β1), leukemia 
inhibitory factor (LIF), interferon gamma (IFN-ϒ) and granulocyte-macrophage colony-
stimulating factor (GM-CSF) (98). 
10.2. T cells  
 
T cells have an important role in immunostimulation and immunoregulation (90).  A 
variety of subpopulations expressing the CD4 marker (CD4+ T cells) exist such as 
helper T cells (Th), type 1 (Th1) and type 2 (Th2), and regulatory T cells. Other 
subpopulations express CD8 marker (CD8+ T cells) denominated by cytotoxic T cells 
(CTLs) (101). CD4+ and CD8+ T cells have an important role against intracellular 
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pathogens and have the capacity to produce IFN-ϒ. The presence and profile of these 
cells subpopulations in the maternal-fetal interface can increase decidual inflammation 
leading to the detriment of pregnancy success (102). 
The primarily function of Th1 cells is the destruction of intracellular pathogens and 
virus-infected cells, and are responsible for the production IL-2 and IFN-ϒ (101). These 
cells can be considered as the major players protecting fetal survival but may also lead 
to pregnancy pathologies. Otherwise, Th2 cells have functions in the eradication of 
helminths and allergic reactions, producing IL-4, IL-13 and IL-5 (102). However, these 
cells during pregnancy have the capacity to overrules Th1 response, constituting a 
major protection to the fetus from maternal Th1 cell response (103). It has been 
observed that Th1 cells are associated with spontaneous abortions or pregnancy 
pathologies (104,105). It have also been reported the presence of Th2 cells in abortion 
cases (106,107). Thus Th1/Th2 paradigm explanation is insufficient and another 
explanation emerged to understand  the rejection of fetus by maternal immune cells 
(90). Recently Th1/Th2/Th17 and regulatory T (Treg) cells paradigm has been 
proposed (108). The Th17 cells also express CD4 marker playing an important role in 
the acute inflammatory response being involved in host defence against extracellular 
pathogens, such as bacteria, fungi or viruses. They are responsible for the production 
of pro-inflammatory cytokine IL-17 (102). An increase of Th17 subpopulation at 
systemic level has been suggested to be harmfull for the pregnant maintenance (109). 
Although, regulatory T (Treg) cells play an essential role in prevention of 
autoimmune disease, they are also able to modulate immune responses during 
infection and exhibit a role in maintaining immune homeostasis (110). Treg cells  have 
an important role in pregnancy, leading to the maintenance of the fetal immune 
tolerance (111). A decline or dysfunctional capacity of Treg cells during pregnancy are 
closely associated with the occurrence of spontaneous abortion or other complications 
(112). In human pregnancy during the first trimester, the Treg cells numbers are 
increased in decidua peaking during the second trimester and lastly declining 
postpartum (113).  
10.3. Decidual Macrophages  
 
Decidual macrophages are the second most abundant leukocyte population in the 
decidua, approximately 20% of total leukocytes (92). However, unlike NK cells, the 
number of macrophages remains high throughout pregnancy (114). 
FCUP 
Determination of macrophages activation and T cell populations in context of congenital 
toxoplasmosis 
17 
 
Macrophages are involved in a diversity of important processes for a successful 
pregnancy such as placental cell invasion, tissue remodeling, immune-cell activities 
and angiogenesis (115). Decidual macrophages in association with dNK cells, 
contribute to the migration of trophoblast and help the remodeling process of spiral 
arteries (93). Otherwise, these cells have a relevant function in apoptotic cells and 
debris clearance originated during placental and vascular remodeling (116).  
Although the diverse roles of these cells, they have an essential role at the 
maternal-fetal interface, in the defence against pathogens protecting the fetus from 
infection (117).  
 Macrophages Activation 
Macrophages were regarded as phagocytic cells responsible for pathogens 
elimination and tissue homeostasis in a broad range of organisms. They have functions 
in both adaptive and innate immunity, being the major-antigen specific cells exhibiting 
different activation profiles (118). 
Macrophages and dendritic cells (DCs) express a diversity of pattern-
recognition receptors, such as Toll-like receptors (TLRs), allowing the recognition of 
pathogens (119). These receptors have an essential role in innate immunity and are 
responsible for the induction of pro-inflammatory cytokines production and upregulation 
of co-stimulatory molecules (120). 
Activation states of macrophage can be divided in M1 (classically activation) or 
M2 (alternative activation). Classically activated macrophages can be induced by IFN-ϒ 
alone or in combination with lipopolysaccharide (LPS) and TNF-α. M1 macrophages 
have a microbicidal and tumoricidal capacity producing high levels of pro-inflammatory 
cytokines and mediators (121). Alternatively activated macrophages can be induced by 
IL-4, IL-13, IL-10 and TGF-β (122), having an important role in parasite clearance, 
tissue remodeling, inflammatory dampening, angiogenesis, allergy response, tumor 
promotion and immunoregulation (123). M2 macrophages can be divided into three 
subclasses: M2a induced by IL-4 and IL-13, M2b induced by exposed to TLR- 
receptors agonists or immune complexes and M2c induced by IL-10 and 
glucocorticoids (124). A study has proposed a fourth type of M2 macrophages profile, 
the M2d, which has similar features to tumor-associated macrophages (TAMs) and is 
characterized by an IL-10high IL-12low profile (Fig.7; 127).  
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Fig.7 – Different types of macrophages polarization profile and the different subclasses of M2 profile. Adapted 
from (126) 
M1 and M2 macrophages are in accordance with Th1/Th2 paradigm, because the 
Th1 cells can produce IFN-ϒ, which causes M1 activation. Otherwise, Th2 cells can 
produce IL-4 and IL-10 associated with M2 activation (127). However, it is notable that  
M1/M2 macrophages occur in all animals, whether they have T cells or not (128). More 
specifically in case of the presence of pathogens or altered self-antigens, M1/M2 
macrophages response has an important role in induced Th1/Th2 responses (127).  
It is known that macrophages have a flexibility in their programming, which means 
that, they have a capacity of switching from activation state to another in response to a 
variety of signals and factors depending on the micro-environmental conditions 
(129,130). Besides, recent in vivo studies have related that macrophages can also 
express, simultaneously, cell M1 and M2 markers in the context of T. gondii infection. 
(131). In accordance, M1/M2 macrophages can be associated with two opposing 
pathways for arginine metabolism. Arginine can be metabolized via inducible nitric 
oxide synthase (NOS2) to NO and citrulline, which is associated with M1 profile. 
Otherwise, arginine can also be metabolized via arginase 1 (Arg-1) to ornithine and 
urea, which is associated with M2 profile (132). 
Actually, it is known that pregnancy is an active, functional and highly controlled 
immunologic process (133). A successful implantation is characterized by a transient 
inflammatory response initiated by cytokines and prostaglandins. In the peri-
implantation period, decidual macrophages present mostly a M1 profile. However, 
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when trophoblast establishes a link to the endometrium and invades the uterine 
stromal, decidual macrophages initiate a transition to mixed M1/M2 profile (134). This 
mixed M1/M2 profile is maintained through the first trimester and in an initial phase of 
the second trimester (133). After placental development, the activation profile of 
decidual macrophages changes toward to M2 profile avoiding rejection of the fetus and 
allowing the fetal growth until parturition (115). 
A recent in vivo study in rats demonstrated that T. gondii acute infection was 
associated with M1 profile, interfering with physiological balance of pregnancy and 
possibly leading to maternal pregnant failure, such as abortion (135).  
10.4. Dendritic cells   
 
Dendritic cells (DCs) are a type of antigen presenting cells (APC) with the capacity 
to activate maternal T cells with fetal/placental specificity. These cells have a capacity 
of recognizing pathogens, through the pattern-recognition receptors, as Toll-like 
receptors (136). dDCs are present in the first trimester of pregnancy, specifically of the 
decidua, (92) declining after implantation and remaining a few cell numbers near the 
developing placenta. The reduction of decidual DCs is critical for fetomaternal 
tolerance, being also responsible, in specifically conditions for inducing a T cell 
response to placental antigens and consequently leading to the failure of pregnancy 
(136). One possible explanation is the expression of indoleamine 2,3 dioxygenase 
(IDO) by DCs, at the maternal-fetal interface suppressing T-cell responses (137,138). 
Studies using decidua from early human pregnancy, have shown an increase of IL-12 
production by myeloid dDCs,  inducing a Th2 response and, consequently, leading to 
pregnancy maintenance (98).  
11. The immunobiology response to T. gondii 
 
T. gondii is frequently acquired by oral ingestion and actively crosses the intestinal 
epithelium, disseminating to other organs, tissues, and cells (139). The intestinal 
epithelium is the first line of defense against T.gondii (24). The infected cells have the 
capacity to secrete cytotoxic molecules which attract diverse immune cells, such as 
DCs, macrophages, neutrophils and T cells (24,140).   
Neutrophils are important phagocytic cells that in presence of pathogens are rapidly 
recruited from bloodstream to the site of infection. These cells kill pathogens by 
releasing an anti-microbial compounds from their granules and production of ROI and 
NO (141). Furthermore, activated neutrophils can also produce a diversity of 
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chemokines, such as IL-8, macrophage inflammatory protein-1α (MIP-1α) and MIP-1β. 
The secretion of these MIP chemokines attract T cells, macrophages, monocytes and 
DCs (141). During the T. gondii infection early neutrophil induction is dependent on IL-
17 signaling, which permits to eliminate a large number of parasites in the initial stage 
(142). 
 The maturation and activation of DCs in response to infection have a fundamental 
role in the initiation of innate immunity and consequently in adaptive immunity 
development. This maturation is characterized by an up-regulation of the expression of 
MHC molecules and diverse co-stimulatory molecules increasing the proliferation T 
cells (143). In response to microbial stimuli, DCs are also able to carry microbial 
antigens from the local of infection to the spleen accumulating in the T cells areas. 
Additionally, DCs are responsible for antigen-presenting activity leading to the 
polarisation of Th responses toward Th1 by the production of IL-12 (144,145). Indeed, 
DCs are the main source of IL-12 in response to T. gondii infection (146). 
Macrophages, such as DCs, provide a first line of defense against initial 
dissemination and/or growth of infectious parasite (147). In the presence of T. gondii 
macrophages, DCs and neutrophils are important source of IL-12 in the initial stage 
(148). IL-12 is essential in the stimulation of NK cells and T cells to produce IFN-ϒ, as 
well as, promoting the proliferation of CD4+ and CD8+ T cells (144).  
NK cells are the major source of IFN- ϒ and are able to recognize and kill infected 
cells (149). They can migrate to lymphoid tissue at the site of infection, where they 
release IFN- ϒ inducing classically activate macrophages with enhanced MHC class II 
expression (97). The classical activation is essential to the control of intracellular T. 
gondii infection, leading to the production of inflammatory cytokines, such as TNF, and 
NO.  
There are two essentials signals for classical activation of macrophages. In the first 
place IFN-ϒ is release by NK or/and T cells and prevented the macrophages. Then, in 
response to the activation of pattern recognition receptors (PRRs) by pathogens-
associated molecules patterns (PAMPs), the endogenous TNF is produced by 
macrophages and completes the activation (24). After macrophages activation, they 
can migrate to the local of infections, phagocytose and destroy pathogens by the 
release of ROI, NO and lysosomal enzymes, as well as by inducing nutrient deprivation 
mechanisms (147,150). However, the overproduction of inflammatory cytokines and 
NO can promote severe pathology, thus the activity of these cells need be tightly 
regulated. So, signals provided by macrophages or surrounding cells, may down-
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regulated macrophages activation resulting in the production of anti-inflammatory 
cytokines, including IL-10 and TGF- β (150).     
CD4+ and CD8+ cells are important in the host survive during a chronic infections. 
CD8+ cells have a main role as effector lymphocytes against the parasite (151). T. 
gondii induces CTLs that have an ability to lyse infected cells (152). Otherwise, CD4+ 
are essential to regulate immune response to T. gondii and have the capacity to 
release several cytokines (153). 
 
12. Animal study model   
 
Murine infection with T. gondii has demonstrated to be one of the most powerful in 
vivo models for the study of fundamental aspects of immune mechanisms controlling 
intracellular parasite infections (154). Although, important parameters for the 
development of infection must be considered as, the strain of parasite, the mouse 
strain and the infection route (Table 3).     
Mice and rats models are frequently used in the study of fetal-placental 
development. Obviously, there are several differences between rodents models and 
humans: the decidualization process in the case of humans can happen spontaneously 
during the late secretory phase of menstrual cycle, but in rat models this process 
occurs only in response to implantation or an artificial stimulus (155); the time of 
gestation in rodents models is approximately between 21-22 days and in humans are 9 
months (92,155); and another critical difference is that placental trophoblast does not 
invade deeply in decidual arterioles in the murine model (92).  
However, the murine and human pregnancy are similar in some events, such as 
placentation and accumulation of dNK cells (92). Although, NK cells are abundant in 
human and rat decidua, in the case of macrophages, they are more abundant in human 
decidua than in murine decidua (92,156). 
Balb/c mice as human don’t have the capacity to transmit T. gondii to the offspring 
during the chronic phase of infection. Vertical transmission occurs when exposition to 
the parasite occurs in specific conditions during pregnancy  (157). Thus, this strain is 
commonly used in the study of vertical transmission of T. gondii. Normally, the T. gondii 
infection occurs in the first period of pregnancy (until 7 days of pregnancy) considering 
the first day of pregnancy as the day on which the presence of vaginal plug occur 
(155,157). Like in humans, the infection in the early stage can result in embryo loss 
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due to abortion or resorption, while infection in the second period (7- 14 days) of 
pregnancy can lead to congenital toxoplasmosis (157).   
As the pregnancy period time is very short (only 21 days), infection in later period 
(14-21 days) typically, are not ethical approved by the competent European Entities 
(DGV;160).  
Table 3 –Strain mice and susceptibility of T. gondii acute infection. Adapted from (154). 
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Aims  
 
During the last years, several scientific advances, have been done to understand 
the immune response to T. gondii. However, there are fewer studies describing how 
maternal immune response during pregnancy may have a role in the pathology 
associated with congenital toxoplasmosis. A diversity of immune cell populations are 
described, as having an important role at the maternal-fetal interface. It is also known 
that under environmental conditions modification, like with infection, the activation 
profile of some of these cell populations, as macrophages and associated T cell 
responses might be implicated in pathological consequences for the fetus.  
In this study, it was used Balb/c mice, a murine strain commonly used as a animal 
model of vertical transmission of T. gondii, allowing the follow-up of pregnancy. We 
aimed to understand the diversity of cell population present during T. gondii infection 
and pregnancy. 
Specifically, we proposed to determine:  
- the effect of infection on basic parameters of reproductive function in 
pregnancy, particularly in the implantation sites number.  
- T.gondii quantification in liver, kidney, heart, lung, and spleen, decidua/placenta 
(E12), decidua (E14) and placenta (E14), embryo (E12, E14), PEC and spleen 
cells.  
- Ex-vivo analysis of neutrophils, macrophages and lymphocytes at PEC and 
spleen cells by flow cytometry.  
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Materials and Methods  
 
1. Parasite 
 
The T. gondii strain used in this study was the Yellow Fluorescence protein (YFP), 
expressing type II strain, corresponding to the ME49 clone, kindly provided from Doctor 
Marcus Meissner laboratory (Parasitology department of the Faculty of Medicine, 
Heidelberg University, Germany). 
 
2. Human Foreskin Fibroblast cells (HFF) in vitro infection 
 
Viable tachyzoites were obtained by in vitro infection of HFF cells provided from 
American Type Culture Collection (ATCC). Cells culture were grown in Dulbecco’s 
Modified Eagle Medium (DMEM; Life Technologies, Paisley, UK) supplemented with L-
glutamine (2mM), fetal bovine serum (10%), 100 U/ml penicillin and 100 µg/ml 
streptomycin. Cell culture were maintained in 75 cm2 and 25 cm2 flasks at 37 ◦C, in 
humidified atmosphere of 5% CO2. Once confluent, HFF were either kept for 
maintaining T. gondii or split for maintenance of the HFF stocks. 
For the maintenance of in vitro parasite cultures, the inoculum concentration 
obtained, was estimated depending on the microscopically observation of the density of 
intracellular tachyzoites, the size of the cell culture flask used, and on the parasite 
numbers needed for the maintenance of the parasite and/or in vivo infection. 
Specifically, when the majority of fibroblasts exhibited multiple intracellular tachyzoites, 
namely in rosettes, fibroblast cells were detached using a cell scraper and disrupted 
using a 25G needle and syringe. Cell suspension was filtered using a 0.45 µm filter and 
centrifuged at 500g for 6 minutes at room temperature, in order to eliminate HFF cell 
debris and resuspended in 1 ml of saline solution (0.9% NaCl). Tachyzoites were 
counted using a Neubauer chamber. When using a confluent 75 cm2 flask of HFF, 
infection was done using 5x106 to 6x106 viable tachyzoites for an incubation period of 
48h to 72h. When using a confluent 25cm2 flask of HFF, infection was done using 
2x105 to 5x105 viable tachyzoites for an incubation period of 48h to 72h. Parasites were 
passaged two or three times a week. 
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3. Pregnant mice and in vivo infection   
 
Balb\cByJ (Balb/c) mice (7-8 weeks old) were purchased from Charles River 
laboratory (France). The maintenance and mating of the animals was done at the 
Institute of Biomedical Sciences Abel Salazar animal facilities (Porto, Portugal) 
supported by the medical veterinary and specialized technicians. Female and male 
animals were mated in cages (ratio 1:1). The appearance of the vaginal plug was 
considered day 1 of gestation (E1). For in vivo infection, the inoculum was prepared in 
saline solution (0.9%NaCl) to a final concentration of the 2,5x104/ mL of viable 
tachyzoites. At the day 7 of gestation (E7), each mice were intraperitoneally (ip) 
infected with 5000 viable tachyzoites obtained, as previously described. After 5 or 7 
days of in vivo infection [corresponding to day 12 and day 14 of gestation (E12, E14)] 
mice were sacrificed. In this study seven groups of mice were used: pregnant T. gondii 
infected (E12-Inf and E14-Inf), pregnant uninfected (E12-Ninf and E14-Ninf), non-
pregnant (E0) 5 or 7 days T. gondii infected (E0-5 days Inf and E0-7 days Inf), non-
pregnant uninfected (E0-Ninf). All procedures involving animals were performed in 
accordance with the recommendations of the European Convention for the Protection 
of Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS 123) 
and directive 2010/63/EU of the European parliament and of the council of 22 
September 2010 on the protection of the animals used for scientific purposes, and 
Portuguese rules (DL 113/2013). The authorization to perform the experiments was 
issued by competent national board authority, Direcção-Geral de Alimentação e 
Veterinária (0421/000/000/2014). 
 
4. Collection of biological samples 
At 5 and 7 days after infection, non-pregnant or pregnant mice (E12 and E14) were 
sacrificed with isofluorane. For each pregnant mouse 3 fetoplacental units (FP) were 
collected and preserved in 4% paraformaldehyde and included in paraffin for 
histological analyses. Other 3 FPs were dissected in decidua/placenta (E12) or decidua 
and placenta (E14) and embryo. For each pregnant or non-pregnant infected animal, 
portions of liver, kidney, lung, spleen and heart were collected and preserved in 4% 
paraformaldehyde and included in paraffin for histological analyses and others were 
stored at -80ºC for DNA extraction. For each animal (from each group) peritoneal 
exudate cells (PEC) were obtained after washing the peritoneal cavity with 7 ml of cold 
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Hanks solution. Spleen cells were obtained after homogenization of a half of the 
spleen, followed by treatment with ACK lysis buffer (0.155 M NH₄Cl, 0.01 M KHCO₃) 
and ressuspended in DMEM supplemented with 10 % FBS. Spleen cells and PEC 
were counted using a Neubauer chamber and processed for flow cytometry and later 
parasite quantification by quantitative real-time PCR (q-PCR). The decidua/placenta 
(E12), decidua or placenta (E14) and embryo (E12 and E14) tissues, PEC, spleen cells 
and organs were stored at -80⁰C in Trizol (1 ml per [50-100] mg of tissue or [5-10] x 106 
cells),  for later  genomic DNA (gDNA),  ribonucleic acid (RNA)  and protein extraction 
according to manufacturer´s instructions  (Sigma Aldrich, USA).  
 
5. Quantitative real-time PCR (q-PCR)  
 
Genomic DNA from the heart, liver, lungs, kidney, spleen, spleen cells, PEC, 
decidua/placenta (E12), decidua or placenta (E14) and embryo (E12, E14) was 
extracted using Trizol Reagent according to manufacturer’s instructions (Sigma 
Aldrich,USA). The DNA concentration was determined using a Thermo Scientific 
Nanodrop 1000 spectophtometer.  
T.gondii genomic DNA was detected using primers and a probe designed for the 
SAG-1 gene of T.gondii, giving rise to an amplification product of approximately 100 
bp. Product amplification was performed with 1 µl of sample DNA, corresponding to 50 
ng  of DNA in a final volume of 10 µl containing 0,2 µM of each primer (SAG-1 forward: 
CCAGAGCCTCATCGGTCGTC; SAG-1 reverse: GGGTCCTTCCGCAGAC AAC), 0,2 
µM of probe (6FAM-CTGTyTGCACCGTAGGAGCACCT-BBQ; all designed by Till 
Molbiol) and KAPA PROBE FAST qPCR Master Mix (Kapabiosystems, USA). The 
PCR programme run was as follows: 1) denaturation at 95⁰C, 3 min; 2) amplification in 
40 cycles (denaturation at 95⁰C, 3 sec; combined annealing/extension 60⁰C, 30 sec). 
The standard curve was obtained using DNA samples corresponding to 10² - 10̄-2 ng/µl 
of parasite DNA diluted in solution of 20 ng/µl of the host DNA. Quantitative evaluation 
of fluorescence signals from PCR products was performed with Step-One Plus (Applied 
Biosystems by Life Technologies) and analysed with Step One Software V2.3. 
6. Flow cytometry analysis 
 
Spleen cells and PEC were isolated from uninfected or infected animals. Briefly a 
single cell suspension was prepared from the spleen and PEC for each mouse, as 
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previously described. Cells were washed and the number of viable cells was counted 
by trypan blue exclusion. For the immunofluorescence staining, cells were labelled with 
distinct combinations of the following antibodies (Abs): Alexa Fluor 647 anti-
mouse/human CD11b antibody (Ab), Isotype rat IgG2b, κ (clone M1/70); PercP/Cy5.5 
anti-mouse Ly6G Ab, Isotype rat IgG2a, κ (clone 1A8); Phycoerythrin (PE) anti-mouse 
Ly6G Ab, Isotype rat IgG2a, κ (clone 1A8); PercP/Cy5.5 anti-mouse F4/80 Ab, Isotype 
rat IgG2a, κ (clone BM8); Purified anti-mouse CD16/32 Ab, Isotype rat IgG2a,   (clone 
93); PE anti-mouse I-A/I-E (MHCII) Ab, Isotype rat IgG2b, κ (clone M5/114.15.2); PE 
rat IgG2b, κ Isotype control (clone RTK4530); allophycocyanin (APC) anti-mouse CD3ε 
Ab, Isotype Armenian hamster IgG (clone 145-2C11); PE anti-mouse CD4, Isotype rat 
IgG2a, κ (clone RM4-5); PE anti-mouse CD8a Ab, Isotype rat IgG2a, κ (clone 53-6.7); 
(all purchased from Biolegend); PE-Polyclonal Sheep IgG anti-Human/Mouse Arginase 
1 (Arg-1); PE-Polyclonal Sheep IgG Isotype control; (both purchased from R&D 
Systems), PE anti-mouse NOS2 Ab, Isotype rat IgG2a, κ (clone CXNFT); PE rat 
IgG2a,κ Isotype control (clone eBR2a); (both purchased from eBioscience). 
Briefly, for the surface staining, 1x106 spleen cells and PEC were seeded in 96- 
well round-bottom plates. For macrophage and neutrophil analysis, Fc blocking was 
performed, incubating cells with anti-mouse CD16/32 Ab during 20 min at 4⁰C. Cells 
were then incubated for 20 minutes with saturating concentrations of the different 
combinations of the following antibodies: CD11b-Alexa Fluor647, F4/80 PercP/Cy5.5 
and Ly6G-PE; CD11b-Alexa Fluor647, F4/80 PercP/Cy5.5 and MHCII-PE or isotype 
control; CD11b-Alexa Fluor647, Ly6G-PercP/Cy5.5 and MHCII-PE or isotype control; 
CD3-APC and CD4-PE; CD3-APC and CD8-PE. Before acquisition, all samples were 
fixed with PBS-Paraformaldehyde 2% (2% PFA) and washed twice in PBS containing 
2% FBS.  
For intracellular staining, 2x106 spleen cells were seeded in 96-well flat-bottom 
plates. After the surface staining for CD11b-Alexa Fluor647, F4/80-PercP/Cy5.5 or 
CD11b-Alexa Fluor 647, Ly6G-PercP/Cy5.5 cells as previously described, the cells 
were fixed with 2% PFA, washed in FACS buffer (PBS, 0.5% BSA, 0.1% NaN3) , and 
washed with permeabilization buffer (PBS, 0.5% BSA, 0.1% NaN3, 0.5% Saponin). 
Cells were then incubated with anti-Arg1-PE or anti-NOS2-PE or isotype-matched 
controls for 30 min at room temperature in the dark. The cells were then washed twice 
with FACS buffer (PBS, 0.5% BSA, 0.1% NaN3) and acquired using a BD accuri C6 
Flow cytometer and software (BD Biosciences).  
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Cells were selected on the basis of FSC-A/SSC-A and the singlets were gated 
according to FSC-H versus FSC-A. Lymphocytes TCD4+ cells were defined as 
CD3+CD4+ and lymphocytes TCD8+ were defined as CD3+CD8+. For each sample,  
acquisition of 10000 events and 1200 events of total CD3+CD4+ or CD3+CD8+, was 
done, to spleen cells and PEC cells, respectively.  
Neutrophils and macrophages were defined as CD11b+Ly6G+ and CD11b+Ly6G-
F4/80+ respectively. For PEC, the data analysis was based on previous studies (158). 
Briefly, small peritoneal macrophages (SPM) were considered as CD11bintF4/80int and 
large peritoneal macrophages (LPM) were considered as CD11bhighF4/80ihigh. For 
spleen cells, M1 macrophages were defined as CD11b+F4/80+NOS2+ and M2 
macrophages defined as CD11b+F4/80+Arg-1+. The population of neutrophils 
expressing NOS2 or Arg-1 was also defined as CD11b+Ly6G+NOS2+ or 
CD11b+Ly6G+Arg-1+. The number of the events acquired for neutrophil and 
macrophage analysis was 10 000 events of total CD11b+ cells. The percentage of 
infected spleen cells and PEC were determined by flow cytometry analysis by the 
evaluation of YFP+ cells in singlets. The number the events acquired for YFP+ cells 
analysis was 10 000 events of total CD11b+ cells. Data were analyzed using FlowJo 
software (Tree Star, Ashland, OR).  
To determine the spleen cell number, the number of gated events for each cell 
population was multiplied by the total cell number (counted using Neubauer chamber) 
and divided by total number of singlets. To determine the percentage of CD11b+Ly6G-
F4/80+ in spleen and PEC cells the correction was done taking account the number of 
events acquired inside the gate CD11b+Ly6G-F4/80+ divided by the total number of 
singlets. 
7. Statistical analyses  
 
Results were expressed as mean + SD. Statistical significance was calculated by 
using the one-way ANOVA test (Fig. 12 C, 13 B, 15, 16, 24 A), two-way ANOVA test 
(Fig. 11 B, 18, 22 A) with a Tukey’s post-test and paired T test (Fig. 22 B and C, 24 B). 
The P values <0.05 were considered statistically significant.  
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Results  
 
1. Maintenance of parasite culture  
 
As previously described in material and methods, viable tachyzoites were obtained 
after the in vitro infection of HFF cells (Fig. 8 A). After 48h or 72h of infection, parasites 
were obtained either to infect Balb/c mice for in vivo experiments and/or used to infect 
new HFF cells for the maintenance of the parasite culture. In Fig. 8 (B-G) images of in 
vitro parasite cultures are shown in different stages of infection.  
 
Fig. 8- In vitro culture of T. gondii-infected HFF cells. A Uninfected HFF; B Extracellular tachyzoite; C-G several 
stages of T. gondii multiplication within HFF; E,F-parasite pairs; D, E,F- rosettes, in the initial stage of formation; C, 
G- rosettes in the final stage of formation. Photos were taken with an inverted light microscope TS100 with a digital 
Sight DS-Fi1 camera using the NIS Elements F Imaging Software (original magnification x200 for [A] and x400 for [B-G]; 
Nikon) 
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It was also observed that in vitro cultures of T. gondii, they exhibited a non-
synchronized multiplication. As observed in Fig. 9, the parasite inside one cell was at 
the initial stage of multiplication (parasite pair) and in other adjacent cell was already in 
active final stage of multiplication (rosettes). Thus, the HFF cell rupture by the parasite 
occurred at different times. 
 
Fig. 9 - T. gondii- infected HFF cells. Yellow circle: Rosette form; Orange circle- Parasite pairs. Photo was taken with 
an inverted light microscope TS100 with a digital Sight DS-Fi1 camera using the NIS Elements F Imaging Software 
(original magnification x400 Nikon) 
 
2. In vivo infection and pregnant Balb/c 
 
In this work, it was used a total of 48 Balb/c animals for in vivo experiments. A total 
of 34 animals were inoculated ip with 5000 viable tachyzoites of T. gondii-YFP+. 
Parasite infection was confirmed after 7 days (E14-Inf and E0-7 days Inf) and 5 days 
(E12-Inf and E0-5 days Inf) post-infection, by flow cytometry analysis of PEC. 
Unfortunately, PEC TOXO–YFP+ were detected in only 18 out of the 34 inoculated 
animals. In the Fig. 10, is shown the evaluation of PEC TOXO YFP+ through of the 
representative histogram of one animal from each group. As it can be observed the 
E14-Inf (B) and E0-7 days Inf (A) mice presented positive PEC-TOXO+ YFP+. 
Therefore, an infection ratio of 1:2 (infected animal: inoculated animals) was 
achieved. This could be explained due to several technical problems, concerning HFF 
cell culture, the influence of the metabolic conditions of host cells can affect the non-
synchronized multiplication of intracellular T. gondii tachyzoites and it may have an 
influence in the number of the viable tachyzoites obtained. However, technical errors in 
the inocula preparation may also affect the obtaining of the viable tachyzoites.  
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In this work, were only shown the results of the confirmed infected animals by the 
detection of PEC-TOXO YFP+ cells (18 animals) and non-inoculated animals (14 non-
infected animals). A total number of 18 pregnant (9 animals for E14 and 9 animals for 
E12) and a total number of 14 non-pregnant animals were considered in this study 
(Table 4 and 5). 
 
Fig. 10- Representative histogram overlay of PEC TOXO YFP+ [A] E0 7 days Inf (blue), E0-5 days Inf (red) and 
E0-Ninf (orange). [B] E14-Inf (blue), E12-Inf (red), E14-Ninf (green) and E12-Ninf (orange).  
 
Table 4 – Number of pregnant Balb/c mice considered in this study. 
 
Table 5- Number of non-pregnant Balb/c mice considered in this study. 
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3. Implantation units  
 
 Several studies using the mice model, describe that T. gondii infection induces an 
increase in the number of resorpted implantation sites, therefore affecting negatively 
pregnancy outcome (159,160). Resorpted units are characterized by a reduction in the 
size and local haemorrhaging as described (159). In a first attempt, total implantation 
units (FP and resorpted units) were macroscopic evaluated and quantified for each 
mouse (Fig.11). The results obtained, show a statistically significant increase of the FP 
unit numbers compared to the resorpted unit numbers for the groups of the analysis 
pregnant animals (Fig. 11B). However, it was not found any difference between E12-Inf 
and E12-Ninf or E14-Inf and E14 Ninf (Fig.11B).  
 
 
 
Fig. 11- Macroscopic evaluation of Implantation units. [A] Representative image from an E12-Ninf mouse uterus, I- 
FP unit; II- Resorpted unit. B Quantification of implantation units. Data represent the mean + SD. Each group 
comprised three to six animals analysed individually. &P<0.05, &&& P<0.001, &&&& P<0.0001 (differences between FP 
units and resorpted units).  
 
4. Pregnancy induces splenomegaly independently of T. gondii 
infection  
 
Using the mice models, infection with different parasites induces splenomegaly, 
indicating an expansion of the immune cells at this secondary lymphoid organ in 
response to infection (161–164). Here is shown that E14-Ninf mice exhibit 
splenomegaly compared to E0-Ninf mice (Fig. 12 A). The same is true, when 
comparing E14-Inf with E0-7 days inf (Fig. 12 B).  These observations indicate that 
pregnancy per si induces an expansion of spleen independently of infection.  
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However, by analysing the total spleen cell numbers of the different groups of 
animals it is observed a significant increase in both E14-Inf and E0-7 days Inf 
compared to E14-Ninf and E0-Ninf mice, respectively. No statically differences were 
observed between E12-Inf and E0-5 days Inf compared to E12-Ninf and E0-NInf mice, 
respectively. These results are not in accordance with spleen macroscopic observation, 
showing that T. gondii induces an expansion of spleen cells independently of the 
pregnancy at day 7 post-infection (Fig. 12 C).  
Fig. 12- Pregnancy and T. gondii infection influence on spleen size and spleen cell numbers. [A] Representative 
images of spleens from E14-Ninf (I) and E0-Ninf (II).  [B] Representative images of spleens from E0- 7 days Inf (I) and 
E14-Inf (II). [C] Total spleen cells numbers obtained using a Neubauer chamber. Data represent the mean + SD. Each 
group comprised three to six animals analysed individually. x P<0.05 (differences between E14-Inf and E14-Ninf, 
respectively) # P<0.05 (differences between E0-7 days Inf and E0-Ninf).  
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5. Parasite load quantification  
 
As previously mentioned, the Balb/c strain is considered susceptible to T. gondii 
acute infection when ip inoculated (154). In this work, the quantification of parasite load 
was performed using samples of several organs (liver, lung, heart, kidney and spleen), 
PEC and spleen cells from infected pregnant or non-pregnant mice by amplification of 
SAG-1 gene by q-PCR.  In the case of pregnant mice, parasite quantification was also 
performed using one FP unit from each animal by amplification of the SAG-1 gene by 
q-PCR. For this, a FP unit was dissected and in E14-Inf mice it was possible to analyse 
the decidua, the placenta and the embryo, and in E12-Inf mice it was analysed 
decidua/placenta tissue (not possible to separate them due to the small size of 
placenta) and the embryo.  
In table 6 and 7, is presented DNA parasite quantification in the different organs, 
PEC and spleen cells from E14-Inf, E0-7 days Inf, E12-Inf and E0-5 days Inf mice. In 
two animals E12-Inf, it was possible to detect the parasite in the liver and in the spleen 
cells, confirming the systemic infection in these animals (Table 6). Additionally, in two 
animals E0-5 days Inf, it was also possible to detect the parasite in spleen cells, in one 
animal the liver and in other one in spleen cells, PEC and spleen (Table 6). Otherwise, 
in E14-Inf and E0-7 days Inf it was possible to detect parasite in the majority of the 
organs, in spleen cells and PEC (Table 7).        
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Table 6- Parasite load quantification in E12-Inf and E0-5 days Inf mice 
     *ND- not-detected 
 
 
Table 7 - Parasite load quantification in E14-Inf and E0-7 days Inf mice 
    *ND-not-detected 
 
 
 
  Parasite DNA (ng/µl) 
 Animal Spleen 
cells 
PEC Liver Lung Heart Kidney Spleen 
 
E12- Inf 
1 ND ND 0,0024 ND ND ND ND 
2 0,0020 ND ND ND ND ND ND 
3 ND ND ND ND ND ND ND 
4 ND ND ND ND ND ND ND 
5 ND ND ND ND ND ND ND 
 
 
E0-5 days Inf 
1 0,0012 ND ND ND ND ND ND 
2 0,0068 
 
ND ND ND ND ND ND 
3 ND ND ND ND ND ND ND 
4 ND ND 21,81 ND ND ND ND 
5 0,0351 4,6776 ND 
 
ND ND ND 0,3110 
  Parasite DNA (ng/µl) 
 Animal Spleen 
cells 
PEC Liver Lung Heart Kidney Spleen 
E14- Inf 1 0,0374 9,0965 
 
0,0485 
 
0,1549 
 
ND ND 0,0528 
 
2 0,0277 4,2048 0,0020 ND ND 0,0036 0,0039 
3 ND ND ND ND ND ND ND 
 
E0-7 days Inf 
1 0,1171 
 
5,6795 
 
0,0169 
 
0,0062 
 
0,0058 
 
0,0017 
 
0,0739 
 
2 0,0252 2,0300 0,0148 ND ND ND 0,0533 
 
3 0,0835 7,5774 0,0039 ND ND ND 0,0128 
4 0,0007 ND ND ND ND ND ND 
5 0,0007 ND ND ND ND ND ND 
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In E12-Inf group analysed it was not detected the parasite in the spleen cells, PEC, 
liver, lung, heart, kidney and spleen, but paradoxically it was detected in 
decidua/placenta tissues in animals 4 and 5 (Table 6 and 8). 
For the E14-Inf and E0-7 days Inf was possible to detected parasite in the liver and 
spleen, indicating a systemic infection. These organs are very important in response to 
T. gondii infection, being that the spleen is the secondary lymphoid organ essential in 
the immunological system and the liver play an essential role in removing of 
pathogens, such as parasites, of the blood (165,166). The results for parasite 
quantification by q-PCR for E14-Inf in the spleen cells (32,6 ± 6,8), PEC (6650,7 ± 
3458,9) and liver (25,2 ± 32,9), and for E0-7 days Inf in the spleen cells (321,6 ± 46,5), 
PEC (5095,6 ± 2819,4), liver (11,8 ± 7,0), they did not allow the achievement of the 
differences between the groups of the analysis animals (Table 7). 
Concerning parasite quantification at the maternal-fetal interface by q-PCR it was 
possible to detect the parasite in three out of the five animals E12-Inf in the 
decidual/placental tissue, but not in the embryo (Table 8). Otherwise, it was possible to 
detect the parasite in two animals E14-Inf in decidua and placenta, and one out of 
three in the embryo, conforming congenital infection in the FP units analysed for this 
animal (Table 9).  
 
Table 8 - Parasite load quantification at FP interface and embryo from E12-Inf mice.  
 
 
 
 
 
 
 
 
 
 
 
 
  Parasite DNA (ng/µl) 
 Animal Decidua/placenta Embryo 
E12- Inf 1 0,0017 ND 
2 ND ND 
3 ND ND 
4 0,0016 ND 
5 0,0071 ND 
*ND-Not- detected 
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Table 9- Parasite load quantification at FP interface and embryo from E14-Inf mice. 
 
 
 
 
 
 
 
Parasite detection was determined in spleen cells and PEC by flow cytometry 
analysis. In Fig. 13 A is presented the gating strategy accomplished, to evaluate the 
percentage of PEC TOXO YFP+ cells. The results indicate that the percentage of PEC 
TOXO YFP+ was increased in E14- Inf and E0-7 days Inf compared to E12-Inf and E0-
5 days Inf mice respectively (Fig.13-B). The sensitivity of flow cytometry method for the 
detection of cell TOXO YFP+ was determined by analysing animals uninfected (1,5 %). 
Therefore, flow cytometry analysis of spleen cells was not able to detect spleen cells 
TOXO YFP+ (Fig.13 C). Since the sensitivity of flow cytometry analysis for the 
quantification of cells TOXO YFP+ was of 1,5% and no parasite was detected by q-
PCR, the animal 5 from E12-Inf (0,53%) and the animal 3 from E14-Inf (1,09%) were  
excluded from the data analysis presented in Fig 13 B and T cells, macrophages and 
neutrophils flow cytometry analysis. The data obtained by flow cytometry analysis for 
E12-Inf and E0-5 days Inf mice, indicate detection of the parasite in PEC (up to 1,5%).  
 
 
 
 
 
 
  Parasite DNA (ng/µl) 
 Animal Decidua Placenta Embryo 
E14- Inf 1 0,0084 0,0059 0,0025 
2 0,0014 0,0007 ND 
 3 ND ND ND 
*ND-Not- detected 
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 Fig. 13 –Quantification of PEC and spleen cells TOXO-YFP+ by flow cytometry. [A] Flow cytometry gating strategy 
to PEC TOXO YFP+ analysis, using the data from E14-Inf mice. [B] Percentage of PEC-TOXO YFP+. [C]Percentage of 
spleen cells TOXO YFP+. Data represent the mean + SD. Each group comprised two to four animals analysed 
individually (E14-Inf, n=2; E0-7 days Inf, n=3; E12-Inf, n=4; E0-5 days Inf, n=5) ****P<0.0001 (difference between E14 
Inf vs E12-Inf and E0-7 days Inf vs E0-5 days Inf). 
 
6. T cell populations  
 
In order to understand how T. gondii infection alters immune cells populations 
during pregnancy it was evaluated by flow cytometry analysis CD4+ T cell and CD8+ T 
cell populations, neutrophils and macrophages in the spleen cells and PEC.  
T cell populations are important players in response to T. gondii infection (152,153). 
To evaluate the CD4+ T cell (CD3+CD4+) and CD8+ T cell (CD3+CD8+) populations at 
systemic level, the flow cytometry was performed using the spleen cells and PEC from 
different groups of mice: E12-Inf, E14-Inf, E0-7days Inf, E0-5 days Inf, E0-Ninf, E12-
Ninf and E14-Ninf. In Fig. 14, it is presented the gating strategy performed for analysis 
of PEC and spleen cells.  
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Fig. 14 – Representative flow cytometry gating strategy used to define CD4+ and CD8+ T cells in PEC [A] 
and in spleen cells [B]. 
 
Fig. 15, presents the percentage of the CD3+CD4+ and CD3+CD8+ for the different 
groups analysed. The results obtained for CD3+CD4+ indicate a significant increase in 
E0-5 days Inf compared to E12-inf and E0-Ninf. It is also observed an increase in 
CD3+CD4+ in E0-7 days comparatively to E0-Ninf (Fig. 15 A). However, E12-Inf 
animals present a significant decrease of percentage of CD3+CD4+, which indicates 
that infection, in the context of pregnancy, doesn’t induce the recruitment of CD3+CD4+ 
for the peritoneal cavity.  
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In the case of CD3+CD8+, the results indicate a significant increase in E14-Inf 
compared to E14-Ninf and a significant increase in E0-7 days Inf comparatively with 
E0-Ninf. 
The evaluation in terms of CD3+CD4+ and CD3+CD8+ numbers was not considered 
due to technical problems during the collection of PEC. The numbers achieved were 
dependent on the volume collected of exudates obtained from each mice and were 
highly variable [between 2-8 x106 cells].  
CD3+CD4+ 
  
CD3+CD8+ 
  
Fig. 15- Evaluation of T cell populations in PEC. [A] Percentage CD4+ T cell population. [B] Percentage of CD8+ T 
cell population. Data represent the mean + SD. Each group comprised two to four animals analysed individually. xx 
P<0.01 (differences between E14-Inf and E14-Ninf). ++ P<0.01 (differences between E12-Inf and E0-5 days Inf). # 
P<0.05, ### P<0.001, #### P<0.0001 (differences between E0-7 days Inf/E0-5 days Inf and E0-Ninf).  
 
A.  
B.  
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The results concerning to spleen cell analysis indicate a significant decrease in 
percentage of CD3+CD4+ and CD3+CD8+ in E14-Ninf and E12-Ninf comparatively to 
E0-Ninf (Fig. 16 A, C). These results indicate that pregnancy induces a decrease in the 
percentage of CD3+CD4+ and CD3+CD8+ independently of the infection. No differences, 
in terms of percentages were obtained, analysing the other animals groups. When 
analysing spleen cells numbers a similar decrease trend of CD3+CD4+ and CD3+CD8+ 
was observed in E12-Ninf and E14-Ninf compared to E0-Ninf but not statically 
significant. However, when analysing the number of the CD3+CD4+ a significant 
increase was found in E14-Inf compared to E14-Ninf and a significant decrease in E14-
Inf comparatively with E0- 7 days Inf (Fig. 16 B). No differences were observed in the 
CD3+CD8+ spleen cell numbers for the other animal groups analysed. 
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CD3+CD4+ 
 
CD3+CD8+ 
   
Fig. 16 – Evaluation of T cell populations in spleen cells. [A] Percentage of CD4+ T cells population. [B] Number of 
CD4+ T cell population. [C] Percentage of CD8+ T cells population. [D] Number of CD8+ T cell population. Data represent 
the mean + SD. Each group comprised two to four animals analysed individually. * P<0.05, **P<0.01, *** P<0.001, 
(differences between E14-Ninf, E12-Ninf and E0-Ninf). x P<0.05 (differences between E14-Inf and E14-Ninf). ++ P<0.01, 
(differences between E14-Inf and E0-7days Inf).  
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7. Macrophage and neutrophil populations   
 
Neutrophils and macrophages constitutes the first line of defense in the initial stage 
of T. gondii acute infection (142,147). To evaluate these two immune cell populations 
at a systemic level and in the local of infection, during T. gondii infection and in the  
pregnancy, flow cytometry analysis were performed using spleen cells and PEC. The 
cells were labelled with a combination of CD11b, Ly6G and F4/80 antibodies, as 
described in material and methods section. The gating strategy used for this analysis is 
presented in Fig. 17. PEC analysis indicated a significant increase of granulocytes 
(CD11b+) and neutrophils (CD11b+Ly6G+) in E14-Inf relatively to E14-Ninf and E0-7 
days Inf comparatively to E0-Ninf mice (Fig.18 A). These results indicate that at 7 days 
post-infection a recruitment of the neutrophils occurs independently of the pregnancy. 
For spleen analysis, the results obtained for percentage and cell number were 
concordant, concerning the comparison between E14-Inf and E14-Ninf, E0-7 days Inf 
and E0-Ninf, E12-Inf and E0-5 days Inf. Thus, an increase of CD11b+ (percentage and 
cell number) was found in E14-Inf compared to E14- Ninf, and in E0-7 days Inf 
compared to E0-Ninf animals. These results indicate that granulocyte recruitment 
occurs in response to infection, independently of the pregnancy. It was found a 
significant decrease of CD11b+ (percentage and cell number) in E12-Inf compared to 
E0-5 days Inf. In terms of percentage it was found a decrease of total CD11b+ in E12-
Inf compared to E0 Ninf. However, no differences were obtained for CD11b+Ly6G+ or 
CD11b+Ly6G-F480+ in terms of percentage in all animals groups analysed. It was found 
an increase in spleen cells number of CD11b+Ly6G+ in E14-Inf vs E14-Ninf, E0-7 days 
Inf vs E0-Ninf and E12-Inf vs E12-Ninf. These results may indicate an increase of the 
neutrophils recruitment in response to infection independently of pregnancy. It also 
may be noted that in terms of percentage there is an increase of CD11b+ in PEC 
(59,9%) compared to spleen cells (5,0%) of  E0-7 days Inf animals. 
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Fig. 17 –Representative flow cytometry gating strategy used to define granulocytes (CD11b+), neutrophils 
(CD11b+Ly6G+) and macrophages (CD11b+ Ly6G-F4/80+) in PEC [A] and spleen cells [B]. 
 
 
Spleen cells 
PEC 
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Fig. 18– Evaluation of granulocytes (CD11b+), neutrophils (CD11b+Ly6G+) and macrophages (CD11b+Ly6G- 
F4/80+) in PEC [A] spleen cells percentage [B] and spleen cells number [C.]. Each group comprised two to four 
animals analysed individually. Data represent the mean + SD. * P<0.05, (differences between E12-Ninf and E0-Ninf). x 
P<0.05,xxx P<0.001, xxxx P<0.0001 (differences between E14-Inf/E12-Inf and E14-Ninf/E12-Ninf, respectively). + P<0.05, 
(differences between E12-Inf and E0-5 days Inf,). ### P<0.001, #### P<0.0001 (differences between E0-7 days Inf and E0-
Ninf).  
 
8. Arg-1 and NOS2 expression macrophages and neutrophils 
 
As previously mentioned, macrophages have two activation profiles: M1 and M2 
stages (150). To evaluate the macrophages activation at systemic level during T. gondii 
infection, the flow cytometry analysis was performed using spleen cells from the 
different groups, previously described. Flow cytometry was used for the analysis of the 
neutrophils (CD11b+Ly6G+) and macrophages (CD11b+F4/80+) expressing Arg-1 and 
NOS2. The gating strategy used for this analysis is shown in Fig.19. 
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 Fig. 19 – Representative flow cytometry gating strategy used to define spleen M1 (CD11b+F4/80+NOS2+) 
and M2 (CD11b+F4/80+Arg-1+) macrophages [A] and spleen neutrophils expressing NOS2 (CD11b+Ly6G+NOS2+) 
and Arg-1 (CD11b+Ly6G+Arg-1+) [B].  
Arg-1 and NOS2 were not detected in our experimental conditions. The results 
indicate negative staining for Arg-1 and NOS2 in the spleen cell ex-vivo analysis for all 
the groups of mice analysed (Fig.20).  
B.  
A.  
CD11b+Ly6G+ 
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Fig. 20 – Evaluation of macrophages [A, B] and neutrophils expressing Arg-1 and NOS2 [C, D]. The cells 
were labelled with two combinations (CD11bF4/80 or CD11bLy6G) and subsequently labelled with intracellular antibodies 
(Arg-1, NOS2 and isotype antibody control). Each group comprised two to four animals analysed individually. Data 
represent the mean + SD.  
 
 
9. MHC II expression in macrophages  
 
Macrophages and other phagocytic cells (like dendritic cells) have the capacity of 
T. gondii phagocytosis and are able to present antigens to CD4+ T cells. Normally, 
these cells are denominated antigen-presenting cells (APCs), which expressed MHCII 
molecules. Macrophages are also characterized by a MHCII increase expression after 
pro-inflammatory stimulation (167). To evaluate the percentage of MHCII+ cells during 
T. gondii acute infection, flow cytometry analysis were performed using spleen cells 
and PEC. The values are expressed as Mean Fluorescence Intensity (MFI) for MHCII 
inside CD11b+F4/80+ cell population. The gating strategy used for PEC analysis is 
shown in Fig. 21.  
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Fig. 21- Representative flow cytometry gating strategy used to define CD11bhighF4/80highMHCII+ (LPM) and 
CD11bintF4/80intMHCII+ (SPM) in PEC. [A] Data from E0-Ninf animal. [B] Data from E14-Inf animal. 
 
First, we performed the evaluation of the MHCII MFI versus an isotype control to 
verify the antibody binding specificity (Fig.22 B, C and 24 B). 
The analysis of PEC flow cytometry data was performed according to other studies 
(158). In this study, LPM are defined as CD11bhighF4/80high and SPM are defined as 
CD11bintF4/80int. To verify the specificity and the expression of MHCII in LPM and 
SPM, the isotype control was used at the same time in the surface stanines. 
A.  
B.  
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The data indicate that LPM disappear in response to T. gondii infection (E14-Inf and 
E0-7 days Inf compared to E14-Ninf and E0-Ninf, respectively; Fig. 22 A). A significant 
decrease of LPM was observed in E0-5 days Inf compared to E0-Ninf (Fig. 22 A). SPM 
were also detected in all animal groups (Fig. 22 A). However, there seems to be an 
increase between E0-7 days Inf vs E14-Inf and E0- 7 days Inf vs E0-Ninf.  
As expected to MHCII expression was higher in SPM population (154300 ± 765,8), 
when compared to LPM population (4291 ± 872,3) in E0-Ninf animal group, as 
previously described (158). For MHCII analysis in spleen cells, we used the gating 
strategy shown in Fig. 23. 
 
 
 
Fig.22- Evaluation of MHCII in LPM and SPM. [A] Percentage of LPM and SPM. [B] Evaluation of the MHC II MFI 
versus isotype control for SPM. [C] MHCII MFI versus isotype control for LPM. Each group comprised two to four 
animals analysed individually. Data represent the mean + SD.  &P<0.05, && P<0.01 (differences between MHCII MFI 
versus isotype control). + P<0.05 (differences between E14-Inf and E0-7days Inf). # P<0.05, ## P<0.01, ### P<0.001, 
(differences between E0-7 days Inf, E0-5 days Inf and E0-Ninf). 
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Fig.23- Representative flow cytometry gating strategy used to define MHCII CD11b+F4/80+ spleen cells. 
 
The results indicate a specific MHCII expression in spleen CD11b+F4/80+ cells 
except for E0-Ninf and E14-Ninf (Fig.24 B). A decrease of CD11b+F4/80+MHCII+ 
percentage was observed in E12-Inf vs E12-Ninf and E12-Inf vs E0-5 days Inf 
indicating that T. gondii infection interferes during pregnancy with macrophages MHCII 
expression.  
 
 
Fig.24- Evaluation of MHCII in spleen cells. [A] Evaluation spleen CD11b+F4/80+MHCII+ cells [B] Evaluation of MHCII 
expression. Each group comprised two to four animals analysed individually. Data represent the mean + SD. &P<0.05, 
&& P<0.01, (differences between MHCII MFI versus isotype control), xxxx P<0.0001 (differences between E12-Inf and E12-
Ninf). ++ P<0.01 (differences between E12-Inf and E0-7days Inf). 
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Discussion  
 
T. gondii is one protozoan parasite that infects billions of people in diverse areas of 
the world. The parasite infection is normally asymptomatic, but in immunocompromised 
hosts it has a diversity of the clinical manifestation (55). Also, a primo-infection during 
pregnancy can lead to fetus clinical manifestation or even abortion depending on the 
gestation period (168). T. gondii has the capacity of crossing biological barriers, such 
as the intestine or the placenta, thereby, disseminating through the blood flow and 
reaching several organs of the intermediate host (169). Murine models are used in the 
study of T. gondii infection and in the understanding of the fundamental immune 
mechanisms, which control intracellular parasite infection (154). Also, murine models 
are frequently used in the study of fetal-placental development. In this work, it was 
used the Balb/c strain infected with viable tachyzoites of T. gondii type II strain. 
However, the obtainment of the infected mice was very difficult.  
As previously described to obtain viable tachyzoites in vitro is needed a host cell. In 
this study we used the HFF cells. The use of HFF cells have several advantages, such 
as the large and flat morphology permitting multiple cycles of parasite replication within 
each cell, the presence of contact inhibition, thus allowing the confluent monolayer to 
remain many weeks until being needed and HFF cells also supply a host comparable in 
some aspects to a clinical infection (170). However, HFF has two important 
disadvantages: the slow growth, particularly of the cells with elevated passage number, 
and a limitation of the replication lifespan (170). 
Differences in the culture, such as passage number, age and density, can lead to 
significant differences in their capacity of keeping parasite growth (170). Therefore, in 
this work, some problems in the maintenance of the HFF culture occurred, because the 
stock vial cells weren’t in the best conditions, due to the cells age. During the first 
couple of months, HFF didn’t grow easily, and subsequently, affected the multiplication 
of the parasite. Moreover, as shown in this work is very difficult to get synchronous 
infection with T. gondii, being the time between infection and cell lysis very variable. In 
this study, 16 of the inoculated mice didn’t present infection and the number of infected 
mice was much reduced. The data from flow cytometry analysis of spleen cells and 
PEC populations were related to only two E14 - Inf mice presenting similar infection, 
three E0-7 days Inf mice, four E12-Inf mice and four E0-5 days Inf mice.  
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A recent work describes that a non-virulent T. gondii infection may cause 
pathological consequences without vertical transmission (160). After maternal T. gondii 
infection, parasite can cause different types of damage including increased of 
resorpted units, extensive haemorrhages or local haemorrhaging and offspring 
absence (160). Macroscopically evaluation of implantation sites and spleen of infected 
and non-infected mice was evaluated. It was observed between 2-3 resorpted units 
and between 8 to 9 FP units in all groups of animals, indicating that in our study model, 
T. gondii infection was not inducing increase resorption rate. Additionally, one of the 
E12-Inf mice presented offspring absence (data not show). At present, volumetric 
analysis of decidua and placenta collected during this work are being performed in 
order to verify the effect of T. gondii infection at the maternal-fetal interface. Another 
macroscopic observation was splenomegaly in E14-Inf and E14-Ninf mice. These 
observations suggest that pregnancy per si induces an expansion of spleen in both 
infected and uninfected mice. The literature also suggests that pregnancy and infection 
with T. gondii  in murine model induces a severe splenomegaly (163,164).   
One of the aims of this study, was the quantification of the parasite in several 
organs, such as liver, lung, heart, kidney and spleen by q-PCR. These results indicate 
that after 5 days of infection, the parasite was not detected in the majority of the 
organs. Otherwise, in animals with 7 days of infection, it was possible to detect parasite 
in the majority of the organs. In the context of pregnancy, the quantification of the 
parasite was also performed in decidua/placenta and embryo tissues. After 5 days of 
infection, was detected the presence of the parasite in decidua/placental tissues of two 
animals, but not in the embryo indicating no vertical transmission. After 7 days of the 
infection is detected parasite in the decidua and in the placenta of two animals 
analysed and in the embryo of one of three animals, indicating vertical transmission. 
Flow cytometry analysis of PEC-TOXO YFP+ allowed the parasite detection in all 
considered infected mice in our experimental conditions, compared with q-PCR 
technique. Also, it allowed parasite detection, indicating an increase in cells–TOXO 
YFP+ in E14-Inf mice compared to E12-Inf mice.  
In the literature it is described that pregnant mice are more susceptible to T.gondii  
infection compared with non-pregnant mice (171). Previous studies by us suggested 
that pregnancy has a protective effect against T. gondii infection in Balb/c mice (data 
not show). However, since the data obtained by us are contradictory between the two 
experimental sets, concerning parasite load in pregnant infected compared to non-
pregnant infected mice, more experiments will be needed. 
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T cell populations have an important role in the host defence against T. gondii 
infection. During early acute infection an increase of the CD4+ and CD8+ T cells 
proliferations occurs (152,172). CD4+ T cell has an essential role to regulate the T. 
gondii immune response and CD8+ T cell plays an important role in intracellular 
pathogen clearance (102,153). In this study, it was evaluated T cell populations at 
systemic level (spleen cells) and in the local of infection (PEC). The results obtained 
indicated that during pregnancy, a decreased percentage of CD3+CD4+ and CD3+CD8+ 
were observed in the spleen. It is known, that maternal immune system tolerate the 
presence of the fetus by a suppression of immune responses (173). This way, the 
decrease percentage of T cell populations in spleen cells from pregnant non-infected 
mice in our experiments may be associated to a decrease in the maternal immune 
system response that contributes to fetal tolerance. It was observed an increase of 
PEC CD4+ T cells in E0- 7 days Inf and E0-5 days Inf mice compared to E0-Ninf, and 
an increase of the PEC CD8+ T cells in E14-Inf and E0- 7 days Inf mice, compared to 
E14-Ninf and E0-Ninf, respectively.  These results indicating that infection induces the 
T cell recruitment and/or proliferation at the local of infection in early stages of T. gondii 
infection, as already reported in other studies (172,174,175).  
Neutrophils are phagocytic cells that during T. gondii infection are rapidly recruited 
to the local of infection (24). Here, is observed a significant increase of the neutrophils 
percentage in E14-Inf and E0-7 days Inf compared to E14-Ninf and E0-Ninf. The 
results obtained indicate a significant increase of spleen neutrophils (CD11b+Ly6G+) in 
number from E14-Inf, E0-7 days Inf and E12-Inf mice, but not in E0-5 days Inf mice 
when compared to the corresponding uninfected animal groups. Parasite quantification 
allowed the detection of the parasite in the spleen of E14-Inf mice, indicating that T. 
gondii induces the recruitment of neutrophils to the spleen.  
Macrophages are phagocytic cells with an essential role in the recognition and 
elimination of pathogens, such as T. gondii (24). Polarity macrophages can be divided 
in M1 or M2 activation profile. M1 macrophages are characterized by the expression of 
NOS2, responsible for the metabolization of arginine to nitric oxide and citruline. M2 
macrophages express the enzyme arginase-1, which is responsible for the hydrolysing 
arginine into ornithine (132). Macrophages analysis was evaluated in PEC and spleen. 
The results obtained for PEC and spleen cells (percentage and number) did not 
presented significant differences in macrophages (CD11b+Ly6G-F4/80+) between the 
different groups analysed. However, when analysing results obtained seems to be an 
increased (but not statically significant) of CD11b+Ly6G-F4/80+ in PEC of the E14-Inf 
and E0- 7 days Inf mice, when compared with the other groups. Macrophages 
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activation was evaluated by flow cytometry analysis of NOS2 and Arg-1 MFI. 
Nevertheless, the results obtained were not conclusive, since specific binding was not 
found. Mores studies will be performed in order to evaluate NOS2 and Arg-1 
expression by flow cytometry analysis of PEC. Other markers are used to define the 
activation profile of macrophages, like MHCII which it is a marker for the M1 profile or 
classical activation (126). MHCII molecules have an important function in peptide 
presentation by APC (macrophages, dendritic cells) to T cells. These molecules can be 
divided into class I and the class II, which interact with CD8+ and CD4+ T cells, 
respectively (176).  
In literature, is described the peritoneal macrophages characterization in two 
subtypes: LPM and SPM (158). Differences in MHCII expression using control Balb/c 
mice are described allowing the description of SPM with increased MHCII MFI (60000) 
compared to LPM (Not detected; 159). Our results are in agreement with this 
observation, being the MHCII MFI for SPM increased in E0-Ninf mice (154300) 
compared to LPM for E0-Ninf mice (4291). In literature, it was suggested that the 
peritoneal macrophages after an in vivo stimulation with lipopolysaccharide (LPS) or 
thioglycolate lead to a decrease of LPM and an increase of SPM by ex-vivo analysis 
(158). Our results indicate that T. gondii infection induces the disappearance of the 
LPM.  
Spleen cells analysis indicated that specific detection of MHCII were observed in 
E14-Inf, E0-7 days Inf, E12-Inf, E0-5 days Inf and E12 Ninf, but not in E0-Ninf and E14-
Ninf. The data concerning the evaluation of CD11b+F4/80+MHCII+ percentage indicates 
that pregnancy at day 12 decreases the MHCII expression independently of infection 
(E12-Inf vs E0-5 days inf), but infection in the context of pregnancy can also decrease 
the percentage of CD11b+F4/80+MHCII+ (E12-Inf vs E12-Ninf). These may suggest that 
T. gondii may be influencing pregnancy-dependent pathways (as pregnancy hormones-
dependent) interfering with the capacity of MHCII expression (177–179).  
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Conclusion  
 
Toxoplasmosis is a prevalent disease in a large number of countries worldwide, and 
it became a health public problem. Therefore, it is important to understand the 
immunological mechanisms and cell players involved in T.gondii immune response at 
the systemic level during pregnancy and specifically at the maternal-fetal interface 
during T.gondii infection. In this work, the results obtained can be divided into two 
levels: the maternal-fetal interface and the systemic level.  
Thus, using our experimental study model, the results obtained by macroscopic 
analysis indicated that T.gondii infection did not induce an increase of resorption rate. 
T.gondii parasite load quantification at the maternal-fetal interface was indicated that 
the parasite did not reach the embryo after 5 days of infection. However, it was 
possible to detect the parasite in one embryo from 1 out of the 3 mice analyzed after 7 
days of infection. At the systemic level, it was observed that 5 days after T.gondii 
infection, the parasite was not able to disseminate from the local of infection 
(intraperitoneal cavity) to the lung, heart, and kidney. Otherwise, it was possible 
detected T.gondii in the majority of the organs after 7 days of infection.  
 Concerning the characterization of immune cell populations, the results indicated 
that T.gondii infection induced an increase of TCD4+, TCD8+ and CD11b+Ly6G+ in the 
local of infection and an increase of TCD4+ and CD11b+Ly6G+ in the spleen 
independently of the pregnancy. The results obtained did not show differences in the 
CD11b+Ly6G- F4/80+ between the animal groups analysed. However, it was possible to 
show a decrease of CD11b+F4/80+MHCII+ spleen cells at day 12 of pregnancy, in 
response to infection.In our experimental conditions, Arg-1 and NOS2 expression was 
not detected in spleen cells by flow cytometry. Lastly, flow cytometry analysis indicated 
that was not possible to detect LPM after T.gondii infection independently of 
pregnancy. The results obtained, indicate that further functional characterization of the 
immune cell populations studied here, must be performed at the systemic level, but 
also at the maternal-fetal interface, specifically at day 7 of infection, in order to deep 
understand a putative role during congenital toxoplasmosis.  Also, the results obtained 
suggests that T.gondii may be influencing pregnancy-dependent pathways (as 
pregnancy-hormone dependent) interfering with the capacity of MHCII expression.  
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